The Cell and Gene Therapy Unit (UTCG) has been designed to meet requirements ranging from conception to administration of cellular products. Under the direction of Nantes University Hospital, UTCG has more than 20 years of experience in the production of clinical batches which are delivered in accordance with Good manufacturing Practice (GMP), guaranteeing their quality, safety and traceability. Its activity is centred on phase I/II studies, corresponding to the concept of an exploratory platform in the field of advanced therapies.

Quality labels and accreditations

  • ISO 9001 certification since 2003
  • French Health (ANSM) authorizations for ATMP hospital exemption activities and allogenic haematopoietic stem cells
  • GMO approvals from the French Ministry of Research for the use of GMOs of class 2, L2 containment in connection with specific projects
  • Regional Health Agency authorization for the pharmaceutical management of ATMP